Can-Fite BioPharma Ltd. CANF

$ 1.94 -2.02%

Annual report 2023
added 11-23-2024

Can-Fite BioPharma Ltd. Financial Statements 2011-2024 | CANF

Annual Financial Statements Can-Fite BioPharma Ltd.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	2.74 B	2.07 B	647 M	706 M	185 M	700 M	1.22 B	775 M	757 M	847 M	34.6 M	25.6 M	-
Shares	1.28 B	816 M	553 M	358 M	85.9 M	38.9 M	32.5 M	28.1 M	23 M	17.5 M	457 K	335 K	-
Historical Prices	2.14	2.54	1.17	1.97	2.15	18	35.7	26.9	33	48.3	72.8	76.5	-
Net Income	-7.63 M	-10.2 M	-12.6 M	-14.4 M	-12.6 M	-6.57 M	4.99 M	7.02 M	5.07 M	24.5 M	-8.34 M	-5.57 M	-6.7 M
Revenue	-	-	853 K	763 K	2.03 M	3.82 M	847 K	170 K	165 K	-	-	-	469 K
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	2.03 M	3.82 M	847 K	170 K	165 K	-	-	-	469 K
Operating Income	-8.2 M	-10.1 M	-12.8 M	-14.1 M	-12 M	-5.41 M	-	-	-	-	-	-	-
Interest Expense	-	-	227 K	-304 K	-618 K	-1.15 M	-	-	-	-	-	-	-
EBITDA	-	-10.1 M	-12.8 M	-14.1 M	-12 M	-5.4 M	5.01 M	7.04 M	5.08 M	24.5 M	-8.81 M	-5.84 M	-4.74 M
Operating Expenses	-	-	-	-	14 M	9.23 M	8.22 M	8.8 M	6.58 M	7.13 M	-	-	5.27 M
General and Administrative Expenses	2.96 M	3.14 M	3.84 M	158 K	132 K	130 K	2.96 M	2.73 M	2.72 M	11.6 M	4.52 M	-	-

All numbers in USD currency

Quarterly Income Statement Can-Fite BioPharma Ltd.

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	816 M	-	516 M	-	464 M	-	411 M	-	121 M	-	-	-	40.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency